Welcome to our dedicated page for FUSE GROUP HOLDING news (Ticker: FUST), a resource for investors and traders seeking the latest updates and insights on FUSE GROUP HOLDING stock.
Fuse Group Holding Inc (FUST) is a diversified holding company engaged in various business sectors such as technology, finance, and real estate. With a focus on innovation and growth, the company has a strong track record of successful investments and strategic partnerships. Fuse Group Holding Inc is committed to delivering value to its shareholders through smart acquisitions, organic growth, and a solid financial foundation.
Fuse Group Holding Inc. (OTCQB: FUST) announced a letter of intent to acquire E-Mo Biotech Holding Inc. for $100 million, payable in common stock at $1.00 per share. The acquisition will allow Fuse to enter the biotech sector, focusing on vaccine and treatment development, particularly against SARS-CoV-2. E-Mo is currently applying for FDA approval for a phase 4 clinical trial using an existing polio vaccine for COVID-19. This strategic move aims to aid in pandemic control while expanding Fuse's operational landscape within biotechnology.
FAQ
What is the current stock price of FUSE GROUP HOLDING (FUST)?
What is the market cap of FUSE GROUP HOLDING (FUST)?
What is Fuse Group Holding Inc (FUST) known for?
How does Fuse Group Holding Inc create value for its shareholders?
What is the focus of Fuse Group Holding Inc's operations?
